Ford to provide update on Ontario's COVID-19 vaccination program | Canada News Media
Connect with us

Business

Ford to provide update on Ontario’s COVID-19 vaccination program

Published

 on

Further delivery delays of COVID-19 vaccines in Ontario have prompted the provincial government to push back the deadline for administering first doses to all long-term care home residents.

Last week, the province said all residents of long-term care homes in Ontario would be able to receive their first dose of an approved COVID-19 vaccine by Feb. 5, 10 days sooner than originally promised.

But on Tuesday, officials confirmed that in response to scaled back shipments of the Pfizer-BioNTech and Moderna vaccines to Canada from Europe, that deadline has now been pushed back to Feb. 10.

The province says they expect to receive 26,325 doses of the Pfizer vaccine this week and another 27,300 next week, an estimated 80 per cent reduction in the allotment that was previously promised by the federal government.

Ontario will receive 63,400 doses of the Moderna vaccine this week, about 18,000 fewer doses than what was expected, officials confirmed Monday.

The stalled shipments have forced the province to shift its vaccination strategy in recent weeks, providing first doses only to residents in long-term care or high-risk retirement homes and as well as those who live in First Nation elder care homes.

Once sufficient doses are secured, the province says it will continue providing first doses to staff and essential caregivers in long-term care and high-risk retirement homes.

Another 130,000 doses of the Pfizer vaccine are expected to arrive in the province during the week of Feb. 15 and 155,000 are expected to be delivered during the week of Feb. 22. No allocation information has been provided to the province beyond that date.

According to the latest information released by the province, in the remaining weeks of February, 310,000 COVID-19 vaccine doses are expected to be delivered.

Officials say they believe they currently have sufficient vaccine supply to provide second doses to everyone who has received their first dose.

The province has said the second dose of the Pfizer vaccine should be administered no later than 42 days after the first dose.

For residents in long-term care, the interval between doses should be maintained at 21 to 27 days.

To date, more than 70,000 people have been fully vaccinated against COVID-19, receiving both the first and second doses.

Approximately 280,084 doses of the Pfizer vaccine and 61,816 doses of the Moderna vaccine have been administered in Ontario.

Figures provided by the federal government suggested that Ontario would likely see another 80,000 doses of the Moderna vaccine on the week of Feb. 22, although that the number has since disappeared from the government’s website.

Ret. Gen. Rick Hillier, chair of the province’s COVID-19 task force, said he is not sure why Ottawa is no longer providing that information.

“I heard about it just before I came over here to come on to the press conference here and my heart went pitter-patter, quite frankly,” Hillier said at a news conference on Tuesday afternoon. “I don’t know if it is just a number that has disappeared, if it is a computer glitch or an IT glitch, or if there is something else behind it.”

Hillier said the province is currently reaching out to the federal government to find out what is happening with the Feb. 22 allotment.

“I don’t know if somebody was updating to make it actually more, which we’d love to see. I’m simply crossing my fingers hoping that we are not going to see a further reduction in Moderna,” he added.

“I know that the team is communicating to Ottawa now and talking to Ottawa to determine exactly why that number disappeared.”

All public health units have now received vaccine doses but some will need to wait until this week’s delivery before they can finish vaccinating residents of all long-term care homes.

Officials say the province has the capacity to vaccinate nearly 40,000 people per day and is working to triple or quadruple that capacity as soon as it receives sufficient supply from the federal government.

Provincial officials confirmed Tuesday that Health Canada is still reviewing data on other vaccine candidates that are awaiting approval, including AstraZeneca, but an announcement could be made in the next week.

Prime Minister Justin Trudeau confirmed Tuesday that Canada has signed a tentative deal with Novavax to produce vaccines here in Canada if it is approved for use. Domestic production of the vaccine also cannot proceed until construction is complete on the Montreal facility where it will be produced.

“These shipment delays with the Pfizer vaccine have been incredibly disappointing,” Ford said on Tuesday afternoon. “With the uncertainty surrounding a steady supply of vaccines, it’s clear we need to start production of COVID-19 vaccines right here in Canada.”

Source:- CP24 Toronto’s Breaking News

Source link

Continue Reading

Business

Transat AT reports $39.9M Q3 loss compared with $57.3M profit a year earlier

Published

 on

 

MONTREAL – Travel company Transat AT Inc. reported a loss in its latest quarter compared with a profit a year earlier as its revenue edged lower.

The parent company of Air Transat says it lost $39.9 million or $1.03 per diluted share in its quarter ended July 31.

The result compared with a profit of $57.3 million or $1.49 per diluted share a year earlier.

Revenue in what was the company’s third quarter totalled $736.2 million, down from $746.3 million in the same quarter last year.

On an adjusted basis, Transat says it lost $1.10 per share in its latest quarter compared with an adjusted profit of $1.10 per share a year earlier.

Transat chief executive Annick Guérard says demand for leisure travel remains healthy, as evidenced by higher traffic, but consumers are increasingly price conscious given the current economic uncertainty.

This report by The Canadian Press was first published Sept. 12, 2024.

Companies in this story: (TSX:TRZ)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

Dollarama keeping an eye on competitors as Loblaw launches new ultra-discount chain

Published

 on

 

Dollarama Inc.’s food aisles may have expanded far beyond sweet treats or piles of gum by the checkout counter in recent years, but its chief executive maintains his company is “not in the grocery business,” even if it’s keeping an eye on the sector.

“It’s just one small part of our store,” Neil Rossy told analysts on a Wednesday call, where he was questioned about the company’s food merchandise and rivals playing in the same space.

“We will keep an eye on all retailers — like all retailers keep an eye on us — to make sure that we’re competitive and we understand what’s out there.”

Over the last decade and as consumers have more recently sought deals, Dollarama’s food merchandise has expanded to include bread and pantry staples like cereal, rice and pasta sold at prices on par or below supermarkets.

However, the competition in the discount segment of the market Dollarama operates in intensified recently when the country’s biggest grocery chain began piloting a new ultra-discount store.

The No Name stores being tested by Loblaw Cos. Ltd. in Windsor, St. Catharines and Brockville, Ont., are billed as 20 per cent cheaper than discount retail competitors including No Frills. The grocery giant is able to offer such cost savings by relying on a smaller store footprint, fewer chilled products and a hearty range of No Name merchandise.

Though Rossy brushed off notions that his company is a supermarket challenger, grocers aren’t off his radar.

“All retailers in Canada are realistic about the fact that everyone is everyone’s competition on any given item or category,” he said.

Rossy declined to reveal how much of the chain’s sales would overlap with Loblaw or the food category, arguing the vast variety of items Dollarama sells is its strength rather than its grocery products alone.

“What makes Dollarama Dollarama is a very wide assortment of different departments that somewhat represent the old five-and-dime local convenience store,” he said.

The breadth of Dollarama’s offerings helped carry the company to a second-quarter profit of $285.9 million, up from $245.8 million in the same quarter last year as its sales rose 7.4 per cent.

The retailer said Wednesday the profit amounted to $1.02 per diluted share for the 13-week period ended July 28, up from 86 cents per diluted share a year earlier.

The period the quarter covers includes the start of summer, when Rossy said the weather was “terrible.”

“The weather got slightly better towards the end of the summer and our sales certainly increased, but not enough to make up for the season’s horrible start,” he said.

Sales totalled $1.56 billion for the quarter, up from $1.46 billion in the same quarter last year.

Comparable store sales, a key metric for retailers, increased 4.7 per cent, while the average transaction was down2.2 per cent and traffic was up seven per cent, RBC analyst Irene Nattel pointed out.

She told investors in a note that the numbers reflect “solid demand as cautious consumers focus on core consumables and everyday essentials.”

Analysts have attributed such behaviour to interest rates that have been slow to drop and high prices of key consumer goods, which are weighing on household budgets.

To cope, many Canadians have spent more time seeking deals, trading down to more affordable brands and forgoing small luxuries they would treat themselves to in better economic times.

“When people feel squeezed, they tend to shy away from discretionary, focus on the basics,” Rossy said. “When people are feeling good about their wallet, they tend to be more lax about the basics and more willing to spend on discretionary.”

The current economic situation has drawn in not just the average Canadian looking to save a buck or two, but also wealthier consumers.

“When the entire economy is feeling slightly squeezed, we get more consumers who might not have to or want to shop at a Dollarama generally or who enjoy shopping at a Dollarama but have the luxury of not having to worry about the price in some other store that they happen to be standing in that has those goods,” Rossy said.

“Well, when times are tougher, they’ll consider the extra five minutes to go to the store next door.”

This report by The Canadian Press was first published Sept. 11, 2024.

Companies in this story: (TSX:DOL)

Source link

Continue Reading

Business

U.S. regulator fines TD Bank US$28M for faulty consumer reports

Published

 on

 

TORONTO – The U.S. Consumer Financial Protection Bureau has ordered TD Bank Group to pay US$28 million for repeatedly sharing inaccurate, negative information about its customers to consumer reporting companies.

The agency says TD has to pay US$7.76 million in total to tens of thousands of victims of its illegal actions, along with a US$20 million civil penalty.

It says TD shared information that contained systemic errors about credit card and bank deposit accounts to consumer reporting companies, which can include credit reports as well as screening reports for tenants and employees and other background checks.

CFPB director Rohit Chopra says in a statement that TD threatened the consumer reports of customers with fraudulent information then “barely lifted a finger to fix it,” and that regulators will need to “focus major attention” on TD Bank to change its course.

TD says in a statement it self-identified these issues and proactively worked to improve its practices, and that it is committed to delivering on its responsibilities to its customers.

The bank also faces scrutiny in the U.S. over its anti-money laundering program where it expects to pay more than US$3 billion in monetary penalties to resolve.

This report by The Canadian Press was first published Sept. 11, 2024.

Companies in this story: (TSX:TD)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending

Exit mobile version